Loading NAMS charts…
May we use analytics cookies to see how vpside is used, including anonymous session recordings? Accepting also loads the price chart, which sets its own cookies. Essential cookies are always on. Privacy
Loading NAMS comparable companies…
| NAMSNewAmsterdam Pharma Co N.V.(opens in a new tab) | $2.47B | $0.01B | −88.9% | — | −3432.2% | 347.54× | — |
|---|---|---|---|---|---|---|---|
| ALMSAlumis Inc.(opens in a new tab) | $0.86B | $0.01B | — | — | −6204.4% | 116.33× | — |
| ROIVRoivant Sciences Ltd.(opens in a new tab) | $26.60B | $0.01B | −67.6% | — | −7914.8% | 3532.11× | — |
| TVRDTvardi Therapeutics, Inc.(opens in a new tab) | $0.01B | $0.01B | −55.3% | 100.0% | — | — | — |
| HCWBHCW Biologics Inc.(opens in a new tab) | $0.00B | $0.01B | +700.2% | 96.7% | −115.3% | 0.24× | — |
| Medianpeers, excl. NAMS | $0.43B | $0.01B | −55.3% | 98.4% | −6204.4% | 116.33× | — |